Bernard Chloé, Morgant Marie Catherine, Jazayeri Aline, Perrin Thomas, Malapert Ghislain, Jazayeri Saed, Bernard Alain, Bouchot Olivier
Department of Cardiac Surgery, Dijon University Hospital, 21000 Dijon, France.
Department of Digestive Surgery, Dijon University Hospital, 21000 Dijon, France.
Biomedicines. 2023 Mar 22;11(3):979. doi: 10.3390/biomedicines11030979.
During the acute phase of myocardial infarction, the culprit artery must be revascularized quickly with angioplasty. Surgery then completes the procedure in a second stage. If emergency surgery is performed, the resulting death rate is high; 15-20% of patients are operated on within the first 48 h after the myocardial infarction. The timing of surgical revascularization and the patient's preoperative state influence the mortality rate. We aimed to evaluate the impact of surgery delay on morbimortality. Between 2007 and 2017, a retrospective monocentric study was conducted including 477 haemodynamically stable patients after myocardial infarction who underwent an urgent coronary bypass. Three groups were described, depending on the timing of the surgery: during the first 4 days (Group 1, = 111, 23%), 5 to 10 days (Group 2, = 242, 51%) and after 11 days (Group 3, = 124, 26%). The overall thirty-day mortality was 7.1% ( = 34). The death rate was significantly higher in Group 1 ( = 16; 14% vs. = 10; 4.0% vs. = 8; 6%, < 0.01). The mortality risk factors identified were age (OR: 1.08; CI 95%: 1.04-1.12; < 0.001), peripheral arteriopathy (OR: 3.31; CI 95%: 1.16-9.43; = 0.024), preoperative renal failure (OR: 6.39; CI 95%: 2.49-15.6; < 0.001) and preoperative ischemic recurrence (OR: 3.47; CI 95%: 1.59-7.48; < 0.01). Ninety-two patients presented with preoperative ischemic recurrence (19%), with no difference between the groups. The optimal timing for the surgical revascularization of MI seems to be after Day 4 in stable patients. However, timing is not the only factor influencing the death rate: the patient's health condition and disease severity must be considered in the individual management strategy.
在心肌梗死急性期,必须迅速通过血管成形术使罪犯血管再通。然后在第二阶段通过手术完成该过程。如果进行急诊手术,死亡率会很高;15% - 20%的患者在心肌梗死后的头48小时内接受手术。手术再灌注的时机和患者的术前状态会影响死亡率。我们旨在评估手术延迟对病死率的影响。在2007年至2017年期间,进行了一项回顾性单中心研究,纳入了477例心肌梗死后血流动力学稳定且接受紧急冠状动脉搭桥术的患者。根据手术时机分为三组:在头4天内(第1组,n = 111,23%),5至10天(第2组,n = 242,51%)和11天后(第3组,n = 124,26%)。总体30天死亡率为7.1%(n = 34)。第1组的死亡率显著更高(n = 16;14% vs. n = 10;4.0% vs. n = 8;6%,P < 0.01)。确定的死亡风险因素为年龄(OR:1.08;95%CI:1.04 - 1.12;P < 0.001)、外周动脉病变(OR:3.31;95%CI:1.16 - 9.43;P = 0.024)、术前肾衰竭(OR:6.39;95%CI:2.49 - 15.6;P < 0.001)和术前缺血复发(OR:3.47;95%CI:1.59 - 7.48;P < 0.01)。92例患者出现术前缺血复发(19%),各组之间无差异。对于血流动力学稳定的患者,心肌梗死手术再灌注的最佳时机似乎是在第4天之后。然而,时机并不是影响死亡率的唯一因素:在个体管理策略中必须考虑患者的健康状况和疾病严重程度。